Labcorp Holdings Inc.

NYSE:LH Voorraadrapport

Marktkapitalisatie: US$19.0b

Labcorp Holdings Toekomstige groei

Future criteriumcontroles 3/6

Labcorp Holdings zal naar verwachting groeien in winst en omzet met respectievelijk 20.5% en 4.7% per jaar. De winst per aandeel zal naar verwachting groeien met 22.5% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 16.1% zijn.

Belangrijke informatie

20.5%

Groei van de winst

22.5%

Groei van de winst per aandeel

Healthcare winstgroei20.1%
Inkomstengroei4.7%
Toekomstig rendement op eigen vermogen16.1%
Dekking van analisten

Good

Laatst bijgewerkt30 Oct 2024

Recente toekomstige groei-updates

Recent updates

Is Labcorp Holdings (NYSE:LH) Using Too Much Debt?

Oct 19
Is Labcorp Holdings (NYSE:LH) Using Too Much Debt?

When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Sep 12
When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Laboratory Corporation: Difficult To Eye Long-Term Compounding Ability

Sep 11

Investors Still Waiting For A Pull Back In Labcorp Holdings Inc. (NYSE:LH)

Jul 20
Investors Still Waiting For A Pull Back In Labcorp Holdings Inc. (NYSE:LH)

Laboratory Corporation: Limited Upside Visibility, Reiterate Hold

Jun 21

When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Jun 13
When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Here's Why It's Unlikely That Laboratory Corporation of America Holdings' (NYSE:LH) CEO Will See A Pay Rise This Year

May 08
Here's Why It's Unlikely That Laboratory Corporation of America Holdings' (NYSE:LH) CEO Will See A Pay Rise This Year

Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72

Apr 30
Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72

Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72

Apr 15
Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72

Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark

Apr 06
Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark

Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear

Apr 01

Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72

Feb 25
Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72

We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings

Feb 22
We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings

An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued

Feb 21
An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued

Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72

Jan 31
Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72

Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly

Jan 30
Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly

Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72

Jan 15
Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72

Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio

Jan 05
Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio

Laboratory Corporation: Multiple Updates, Same Investment Conclusion

Dec 02

Laboratory Corp.: Rate On Capital Deployed Contracting, Hold

Sep 14

Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea

Jul 05

Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts

Jul 04
Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts

Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?

Jun 23
Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?

Laboratory Corporation: Predictability Of Cash Flows Less Visible

Jun 21

Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?

May 26
Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?

Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher

Mar 16
Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher

Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate

Mar 02
Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate

Winst- en omzetgroeiprognoses

NYSE:LH - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202614,3981,1221,3861,93713
12/31/202513,7621,0381,1491,60016
12/31/202412,9779099451,40616
9/30/202412,7134368431,388N/A
6/30/202412,4884509621,496N/A
3/31/202412,3003997671,276N/A
12/31/202312,1623798741,328N/A
9/30/202312,0585831,0121,397N/A
6/30/202311,8686771,0081,372N/A
3/31/202311,7577891,1221,513N/A
12/31/202211,8641,0021,4171,847N/A
9/30/202212,9901,5181,4151,895N/A
6/30/202214,1861,8291,7882,303N/A
3/31/202215,1042,0281,8262,308N/A
12/31/202113,1362,1952,5973,018N/A
9/30/202116,5552,7632,7773,187N/A
6/30/202116,3882,8792,8363,206N/A
3/31/202115,3162,6432,7193,089N/A
12/31/202013,9791,5561,7542,135N/A
9/30/202012,4428451,5201,931N/A
6/30/202011,4753621,1741,600N/A
3/31/202011,5873211,0701,483N/A
12/31/201911,5558241,0451,445N/A
9/30/201911,3897559671,361N/A
6/30/201911,2928537581,158N/A
3/31/201911,2768968901,292N/A
12/31/201811,3338849261,305N/A
9/30/201811,2911,4141,0301,384N/A
6/30/201811,0811,266N/A1,529N/A
3/31/201810,7431,217N/A1,452N/A
12/31/201710,3081,227N/A1,498N/A
9/30/20179,951724N/A1,382N/A
6/30/20179,702732N/A1,235N/A
3/31/20179,556751N/A1,274N/A
12/31/20169,553712N/A1,197N/A
9/30/20169,295658N/A1,112N/A
6/30/20169,192633N/A1,150N/A
3/31/20169,029599N/A1,197N/A
12/31/20158,506438N/A982N/A
9/30/20157,774447N/A812N/A
6/30/20157,056430N/A699N/A
3/31/20156,353401N/A510N/A
12/31/20146,012511N/A739N/A
9/30/20145,936518N/A774N/A
6/30/20145,846529N/A833N/A
3/31/20145,798540N/A763N/A
12/31/20135,808574N/A819N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei LH ( 20.5% per jaar) ligt boven de spaarquote ( 2.5% ).

Winst versus markt: De winst van LH ( 20.5% per jaar) zal naar verwachting sneller groeien dan de US markt ( 15.2% per jaar).

Hoge groeiwinsten: De winst van LH zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van LH ( 4.7% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.8% per jaar).

Hoge groei-inkomsten: De omzet van LH ( 4.7% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen LH zal naar verwachting over 3 jaar laag zijn ( 16.1 %).


Ontdek groeibedrijven